112 related articles for article (PubMed ID: 11813632)
1. [Quantitative changes in CD4+ and CD8+ T-lymphocytes in the skin of patients with psoriasis treated with cyclosporin A].
Adamicová K; Fetisovová Z; Cingel P; Péc J; Parobeková K; Chromej I
Cesk Patol; 2001 Nov; 37(4):154-7. PubMed ID: 11813632
[TBL] [Abstract][Full Text] [Related]
2. Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.
Larsen R; Ryder LP; Svejgaard A; Gniadecki R
Clin Exp Immunol; 2007 Jul; 149(1):23-30. PubMed ID: 17403057
[TBL] [Abstract][Full Text] [Related]
3. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions.
Dyring-Andersen B; Bonefeld CM; Bzorek M; Løvendorf MB; Lauritsen JP; Skov L; Geisler C
Scand J Immunol; 2015 Jul; 82(1):84-91. PubMed ID: 25904071
[TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
[TBL] [Abstract][Full Text] [Related]
5. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
6. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
7. The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.
Langewouters AM; Bovenschen HJ; De jong EM; Van Erp PE; Van De Kerkhof PC
J Dermatolog Treat; 2007; 18(5):279-85. PubMed ID: 17852631
[TBL] [Abstract][Full Text] [Related]
8. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
9. The changes in T lymphocyte subsets following periodontal treatment in patients with chronic periodontitis.
Erciyas K; Orbak R; Kavrut F; Demir T; Kaya H
J Periodontal Res; 2006 Jun; 41(3):165-70. PubMed ID: 16677283
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
[TBL] [Abstract][Full Text] [Related]
11. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
Erkin G; Uğur Y; Gürer CK; Aşan E; Korkusuz P; Sahin S; Kölemen F
J Cutan Pathol; 2007 Mar; 34(3):213-9. PubMed ID: 17302604
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
Piskin G; Heydendael VM; de Rie MA; Bos JD; Teunissen MB
Arch Dermatol Res; 2003 Mar; 294(12):559-62. PubMed ID: 12624782
[No Abstract] [Full Text] [Related]
13. Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.
Höxtermann S; Nüchel C; Altmeyer P
Dermatology; 1998; 196(2):223-30. PubMed ID: 9568412
[TBL] [Abstract][Full Text] [Related]
14. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.
Eysteinsdóttir JH; Sigurgeirsson B; Ólafsson JH; Fridriksson T; Agnarsson BA; Davíðsson S; Valdimarsson H; Lúðvíksson BR
Scand J Immunol; 2013 Dec; 78(6):529-37. PubMed ID: 24111693
[TBL] [Abstract][Full Text] [Related]
15. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.
Bachelez H; Flageul B; Dubertret L; Fraitag S; Grossman R; Brousse N; Poisson D; Knowles RW; Wacholtz MC; Haverty TP; Chatenoud L; Bach JF
J Autoimmun; 1998 Feb; 11(1):53-62. PubMed ID: 9480723
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subpopulations and concentrations of soluble CD8 and CD4 antigen after anaerobic training.
Weiss C; Kinscherf R; Roth S; Friedmann B; Fischbach T; Reus J; Dröge W; Bärtsch P
Int J Sports Med; 1995 Feb; 16(2):117-21. PubMed ID: 7751074
[TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases.
Thaçi D; Pätzold S; Kaufmann R; Boehncke WH
Br J Dermatol; 2005 May; 152(5):1048-50. PubMed ID: 15888169
[TBL] [Abstract][Full Text] [Related]
19. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
Abecassis S; Giustiniani J; Meyer N; Schiavon V; Ortonne N; Campillo JA; Bagot M; Bensussan A
J Invest Dermatol; 2007 May; 127(5):1161-6. PubMed ID: 17218942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
